Axsome Therapeutics, Inc. (AXSM)
199.02
-7.25
(-3.51%)
USD |
NASDAQ |
Aug 28, 16:00
199.99
+0.97
(+0.49%)
After-Hours: 07:51
Axsome Therapeutics Cash from Investing (Quarterly) : -0.45M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.45M |
| March 31, 2026 | -0.121M |
| December 31, 2025 | -0.071M |
| September 30, 2025 | -0.058M |
| June 30, 2025 | -0.013M |
| March 31, 2025 | -0.338M |
| December 31, 2024 | -0.03M |
| September 30, 2024 | -0.09M |
| June 30, 2024 | -0.052M |
| March 31, 2024 | -0.098M |
| December 31, 2023 | -0.007M |
| September 30, 2023 | -0.371M |
| June 30, 2023 | -0.133M |
| March 31, 2023 | -0.071M |
| December 31, 2022 | -0.1809M |
| September 30, 2022 | -0.0661M |
| June 30, 2022 | -53.24M |
| March 31, 2022 | -0.2137M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.2587M |
| June 30, 2021 | -0.0189M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.03M |
| December 31, 2020 | -0.0203M |
| September 30, 2020 | -0.0148M |
| June 30, 2020 | -0.0014M |
| March 31, 2020 | -0.0093M |
| December 31, 2019 | -0.0015M |
| September 30, 2019 | -0.0032M |
| June 30, 2019 | -0.0115M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.0085M |
| June 30, 2018 | -0.0096M |
| March 31, 2018 | -0.0146M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0036M |
| June 30, 2017 | -0.0034M |
| March 31, 2017 | -0.0029M |
| December 31, 2016 | -0.0061M |
| September 30, 2016 | -0.0763M |
| June 30, 2016 | -0.0116M |
| March 31, 2016 | -0.0107M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -15.40B |
| Liquidia Corp. | -12.24M |
| Filana Therapeutics, Inc. | -0.021M |
| CorMedix, Inc. | -0.561M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.95M |
| Cash from Financing (Quarterly) | 48.15M |
| Free Cash Flow | -71.96M |
| Free Cash Flow Per Share (Quarterly) | -0.6448 |
| Free Cash Flow to Equity (Quarterly) | -38.20M |
| Free Cash Flow to Firm (Quarterly) | -30.19M |
| Free Cash Flow Yield | -0.71% |